Huan Deng Selected Research

Sunitinib (Sutent)

1/2020	A 2/1 Sunitinib Dosing Schedule Provides Superior Antitumor Effectiveness and Less Toxicity Than a 4/2 Schedule for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
5/2019	Pazopanib has equivalent anti-tumor effectiveness and lower Total costs than Sunitinib for treating metastatic or advanced renal cell carcinoma: a meta-analysis.
1/2019	Comparative Efficacy, Safety, and Costs of Sorafenib vs. Sunitinib as First-Line Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Huan Deng Research Topics

Disease

53	Neoplasms (Cancer) 01/2024 - 06/2012
14	Carcinogenesis 03/2023 - 01/2017
14	Infections 01/2023 - 04/2008
12	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 01/2014
11	Stomach Neoplasms (Stomach Cancer) 12/2023 - 01/2019
9	Body Weight (Weight, Body) 12/2023 - 07/2007
8	Neoplasm Metastasis (Metastasis) 11/2021 - 08/2012
7	Obesity 04/2024 - 12/2018
7	Fibrosis (Cirrhosis) 10/2023 - 11/2016
6	Osteoarthritis 12/2022 - 01/2020
6	Kashin-Beck Disease 12/2022 - 01/2021
5	Type 2 Diabetes Mellitus (MODY) 11/2023 - 01/2020
5	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2018
5	Asthma (Bronchial Asthma) 01/2020 - 04/2008
4	Nausea 12/2023 - 01/2022
4	Hypercholesterolemia 12/2023 - 12/2021
4	Inflammation (Inflammations) 06/2023 - 01/2018
4	Hypoxia (Hypoxemia) 02/2023 - 01/2022
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 01/2019
4	Hypertrophy 06/2010 - 04/2008
3	Overweight 12/2023 - 09/2021
3	Colitis 07/2023 - 12/2022
3	Hypertension (High Blood Pressure) 01/2023 - 04/2006
3	Chronic Hepatitis B 01/2023 - 08/2019
3	Pneumonia (Pneumonitis) 01/2022 - 01/2018
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2018 - 01/2015
2	Burns 02/2024 - 01/2019
2	Pain (Aches) 02/2024 - 09/2022
2	Respiratory Tract Infections (Respiratory Tract Infection) 12/2023 - 01/2023
2	Colonic Neoplasms (Colon Cancer) 12/2023 - 01/2017
2	Vomiting 11/2023 - 09/2022
2	Diarrhea 11/2023 - 10/2023
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2023 - 01/2023
2	Ovarian Neoplasms (Ovarian Cancer) 10/2023 - 01/2023
2	Glioma (Gliomas) 10/2023 - 01/2023
2	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 08/2023 - 01/2023
2	Osteosarcoma (Osteogenic Sarcoma) 06/2023 - 05/2018
2	Adenocarcinoma 02/2023 - 11/2018
2	Melanoma (Melanoma, Malignant) 01/2023 - 11/2019
2	Liver Failure 01/2023 - 05/2008
2	Liver Diseases (Liver Disease) 01/2023 - 01/2019
2	Circulating Neoplastic Cells 01/2023 - 05/2014
2	Triple Negative Breast Neoplasms 01/2023 - 01/2020
2	Rheumatoid Arthritis 10/2022 - 10/2017
2	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 11/2021
2	Schizophrenia (Dementia Praecox) 01/2022 - 11/2021

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 04/2024 - 04/2008
6	Monoclonal AntibodiesIBA 12/2023 - 02/2020
6	CateninsIBA 01/2022 - 12/2018
6	LipopolysaccharidesIBA 01/2022 - 08/2006
5	mazdutideIBA 12/2023 - 09/2021
5	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2015
4	Glucagon Receptors (Glucagon Receptor)IBA 11/2023 - 09/2021
4	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2023 - 09/2021
4	Therapeutic UsesIBA 06/2023 - 01/2018
4	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2020
4	Histidine DecarboxylaseIBA 01/2022 - 01/2017
4	Messenger RNA (mRNA)IBA 01/2021 - 12/2017
4	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 05/2018
3	Proprotein Convertase 9IBA 12/2023 - 12/2021
3	oxidized low density lipoproteinIBA 12/2023 - 01/2023
3	LigandsIBA 01/2023 - 01/2014
3	CarcinogensIBA 01/2023 - 02/2016
3	SeleniumIBA 10/2022 - 01/2021
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 05/2019
3	Cadherins (E-Cadherin)IBA 10/2020 - 11/2016
3	Immune Checkpoint InhibitorsIBA 02/2020 - 11/2018
3	Polysaccharides (Glycans)IBA 01/2020 - 05/2018
3	Sunitinib (Sutent)FDA Link 01/2020 - 01/2019
3	AntigensIBA 11/2019 - 11/2016
3	Sorafenib (BAY 43-9006)FDA Link 03/2019 - 01/2019
3	Small Interfering RNA (siRNA)IBA 05/2018 - 04/2008
3	Glycogen Synthase (Synthase I)IBA 06/2010 - 04/2008
3	Glycogen Synthase Kinase 3 betaIBA 06/2010 - 04/2008
2	ChromatinIBA 05/2024 - 08/2012
2	Fibrinogen (Factor I)FDA Link 12/2023 - 01/2015
2	LipidsIBA 12/2023 - 08/2023
2	Long Noncoding RNAIBA 12/2023 - 02/2018
2	dulaglutideIBA 11/2023 - 01/2022
2	LDL CholesterolIBA 08/2023 - 01/2023
2	Dextran SulfateIBA 07/2023 - 12/2022
2	Keratins (Keratin)IBA 01/2023 - 01/2019
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2023 - 01/2018
2	Transcription Factors (Transcription Factor)IBA 01/2023 - 09/2014
2	Interleukin-6 (Interleukin 6)IBA 01/2023 - 01/2014
2	RNA Polymerase IIIIBA 01/2023 - 01/2022
2	VaccinesIBA 01/2023 - 11/2019
2	Alanine Transaminase (SGPT)IBA 01/2023 - 01/2023
2	Neutralizing AntibodiesIBA 01/2023 - 01/2020
2	ChemokinesIBA 01/2022 - 01/2020
2	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2022 - 11/2021
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2022 - 01/2022
2	CytokinesIBA 01/2022 - 01/2022

Therapy/Procedure

15	Therapeutics 01/2024 - 01/2018
6	Drug Therapy (Chemotherapy) 06/2020 - 01/2018
5	Immunotherapy 12/2023 - 11/2018
4	Gastrectomy 09/2022 - 12/2018
3	Length of Stay 02/2024 - 01/2019
2	Radiotherapy 01/2023 - 11/2018
2	Neoadjuvant Therapy 05/2022 - 05/2021